Literature DB >> 8626617

Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats.

D Massillon1, N Barzilai, W Chen, M Hu, L Rossetti.   

Abstract

Overproduction of glucose by the liver is the major cause of fasting hyperglycemia in both insulin-dependent and non-insulin-dependent diabetes mellitus. The distal enzymatic step in the process of glucose output is catalyzed by the glucose-6-phosphatase complex. We show here that 90% partially pancreatectomized diabetic rats have a >5-fold increase in the messenger RNA and a 3-4-fold increase in the protein level of the catalytic subunit of glucose-6-phosphatase in the liver. Normalization of the plasma glucose concentration in diabetic rats with either insulin or the glycosuric agent phlorizin normalized the hepatic glucose-6-phosphatase messenger RNA and protein within approximately 8 h. Conversely, phlorizin failed to decrease hepatic glucose-6-phosphatase gene expression in diabetic rats when the fall in the plasma glucose concentration was prevented by glucose infusion. These data indicate that in vivo gene expression of glucose-6-phosphatase in the diabetic liver is regulated by glucose independently from insulin, and thus prolonged hyperglycemia may result in overproduction of glucose via increased expression of this protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626617     DOI: 10.1074/jbc.271.17.9871

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.

Authors:  K A Bennett; M Hammill; S Currie
Journal:  J Comp Physiol B       Date:  2013-06-07       Impact factor: 2.200

3.  Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen.

Authors:  R M O'Doherty; P B Jensen; P Anderson; J G Jones; H K Berman; D Kearney; C B Newgard
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  In islet-specific glucose-6-phosphatase-related protein, the beta cell antigenic sequence that is targeted in diabetes is not responsible for the loss of phosphohydrolase activity.

Authors:  J-J Shieh; C-J Pan; B C Mansfield; J Y Chou
Journal:  Diabetologia       Date:  2005-07-13       Impact factor: 10.122

5.  Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.

Authors:  Seung-Soon Im; Mi-Young Kim; Sool-Ki Kwon; Tae-Hyun Kim; Jin-Sik Bae; Hail Kim; Kyung-Sup Kim; Goo-Taeg Oh; Yong-Ho Ahn
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

Review 6.  A retrospective review of the roles of multifunctional glucose-6-phosphatase in blood glucose homeostasis: Genesis of the tuning/retuning hypothesis.

Authors:  Robert C Nordlie; James D Foster
Journal:  Life Sci       Date:  2010-07-21       Impact factor: 5.037

7.  Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.

Authors:  Devjit Tripathy; Aurora Merovci; Rita Basu; Muhammad Abdul-Ghani; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

8.  Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription.

Authors:  R S Streeper; E M Eaton; D H Ebert; S C Chapman; C A Svitek; R M O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter.

Authors:  John L Petrie; Ziad H Al-Oanzi; Catherine Arden; Susan J Tudhope; Jelena Mann; Julius Kieswich; Muhammad M Yaqoob; Howard C Towle; Loranne Agius
Journal:  Mol Cell Biol       Date:  2012-12-03       Impact factor: 4.272

10.  Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway.

Authors:  C Xin; J Liu; J Zhang; D Zhu; H Wang; L Xiong; Y Lee; J Ye; K Lian; C Xu; L Zhang; Q Wang; Y Liu; L Tao
Journal:  Int J Obes (Lond)       Date:  2015-09-25       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.